180 related articles for article (PubMed ID: 31424163)
1. Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding.
Gampfer TM; Richter LHJ; Schäper J; Wagmann L; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1572-1580. PubMed ID: 31424163
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl.
Gampfer TM; Wagmann L; Richter MJ; Fischmann S; Westphal F; Meyer MR
J Anal Toxicol; 2020 Apr; 44(5):449-460. PubMed ID: 32020187
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.
Gampfer TM; Wagmann L; Park YM; Cannaert A; Herrmann J; Fischmann S; Westphal F; Müller R; Stove CP; Meyer MR
Arch Toxicol; 2020 Jun; 94(6):2009-2025. PubMed ID: 32249346
[TBL] [Abstract][Full Text] [Related]
4. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
[TBL] [Abstract][Full Text] [Related]
5. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
6. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
7. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
8. Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam.
Wagmann L; Manier SK; Felske C; Gampfer TM; Richter MJ; Eckstein N; Meyer MR
J Anal Toxicol; 2021 Nov; 45(9):1014-1027. PubMed ID: 33048135
[TBL] [Abstract][Full Text] [Related]
9. Studies on the in vitro and in vivo metabolism of the synthetic opioids U-51754, U-47931E, and methoxyacetylfentanyl using hyphenated high-resolution mass spectrometry.
Nordmeier F; Richter LHJ; Schmidt PH; Schaefer N; Meyer MR
Sci Rep; 2019 Sep; 9(1):13774. PubMed ID: 31551531
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products.
Wagmann L; Manier SK; Bambauer TP; Felske C; Eckstein N; Flockerzi V; Meyer MR
J Anal Toxicol; 2020 Jul; 44(6):549-558. PubMed ID: 32104896
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.
Mardal M; Gracia-Lor E; Leibnitz S; Castiglioni S; Meyer MR
Drug Test Anal; 2016 Oct; 8(10):1039-1048. PubMed ID: 26810883
[TBL] [Abstract][Full Text] [Related]
14. Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive Substances.
Manier SK; Niedermeier S; Schäper J; Meyer MR
J Anal Toxicol; 2020 Mar; 44(2):156-162. PubMed ID: 31355413
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
[TBL] [Abstract][Full Text] [Related]
17. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches.
Richter LH; Kaminski YR; Noor F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2016 Sep; 408(23):6283-94. PubMed ID: 27372715
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
Cutler C; Hudson S
Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
Richter LHJ; Maurer HH; Meyer MR
Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
